Page last updated: 2024-08-25

voriconazole and Pulmonary Aspergillosis

voriconazole has been researched along with Pulmonary Aspergillosis in 136 studies

Research

Studies (136)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (8.09)29.6817
2010's85 (62.50)24.3611
2020's40 (29.41)2.80

Authors

AuthorsStudies
Chen, CH; Liu, H; Tang, XL; Zhang, XY; Zhao, SY; Zhou, CJ1
Chen, X; Liang, S; Xu, J; Zhang, L; Zhou, Y1
Li, D; Liu, Z; Qiao, L; Yi, L; Yu, L1
Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE1
Bhalla, AS; Doddamani, S; Guleria, R; Hadda, V; Khan, MA; Madan, K; Mittal, S; Mohan, A; Tiwari, P1
Babaei, M; Daie Ghazvini, R; Erami, M; Fattahi, M; Getso, MI; Hashemi, SJ; Khodavaisy, S; Mehri, N; Momen-Heravi, M; Parviz, S; Raiesi, O1
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M1
Aliakbarian, M; Khaleghi, E; Khodashahi, M; Khodashahi, R; Moghaddam, MD; Naderi, HR; Pasand, MM; Rezayat, KA1
Hirasawa, Y; Matsui, H; Miyakawa-Tanaka, K; Nakamura, S; Narumoto, O; Suzuki, J; Takeda, K1
Chiappini, E; Galli, L; Motisi, MA; Pellegrino, R; Taccetti, G; Terlizzi, V1
Fujita, H; Imataki, O; Ishida, T; Kadowaki, N; Kida, JI; Uemura, M1
Cheng, D; Han, Q; Wang, K; Wu, H; Xiong, X; Zhuo, K1
Abtahian, Z; Jamzivar, F; Marjani, M; Moniri, A; Nasiri, N; Poorabdollah, M; Razzaghi-Abyaneh, M; Salehi, M; Salehi, Z; Shams-Ghahfarokhi, M; Sharifynia, S; Tabarsi, P1
Bellomo, R; Costa-Pinto, R; Finlay, L; Klink, S; Perera, P; Rotherham, H; Trubiano, J; Urbancic, K; Vaz, K1
Salzer, HJF1
Chastain, DB; Henao-Martínez, AF; Thompson, GR1
Dai, X; Gao, C; Jiang, Y; Liu, Q; Liu, X; Shen, L; Sheng, J; Wang, B; Xu, F; Yao, L1
Akata, K; Fukuda, K; Fukuda, Y; Ikegami, H; Ikushima, I; Kawanami, T; Nakamura, M; Noguchi, S; Yamasaki, K; Yatera, K1
Abu Sitta, E; Elsaghir, H; Hollingshead, C; Luttmann, K1
Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS1
Böll, B; Böttiger, BW; Cornely, OA; Dusse, F; Eichenauer, DA; Fuchs, F; Hallek, M; Jung, N; Klein, F; Kochanek, M; Koehler, P; Persigehl, T; Rybniker, J; Shimabukuro-Vornhagen, A1
Bongomin, F; Denning, DW; Garcez, T1
Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL1
Denning, DW; Harris, C; Hashad, R; Kosmidis, C; Lynch, F; Mackenzie, A1
Ananthamurthy, A; Balasundaram, S; Devaraj, U; Krishnaswamy, UM; Ramachandran, P; Savio, J; Venkatnarayan, K1
d'Odémont, JP; Ocak, S1
Baluku, JB; Bongomin, F; Kazibwe, A; Olum, R; Russell, L1
Aggarwal, R; Arul, A; Chaudhary, H; Dey, P; Mukhopadhyay, K; Rawat, A; Ray, S; Vignesh, P1
Bassetti, M; Böll, B; Brüggemann, R; Chakrabarti, A; Chen, SCA; Colombo, AL; Cornely, OA; Gangneux, JP; Hoenigl, M; Klimko, N; Koehler, P; Lass-Flörl, C; Meis, JF; Oladele, RO; Ostrosky-Zeichner, L; Patterson, TF; Perfect, JR; Persigehl, T; Verweij, PE; Vinh, DC; White, PL; Zhu, LP1
Burrow, AJ; Dennison, SR; Gorki, V; Katare, OP; Kaur, R; Kaushik, A; Rudramurthy, SM; Singh, B; Singh, KK; Swami, R1
Choi, E; Kim, JH; Kim, SB; Yoon, YK1
Antinori, S; Bartoletti, M; Cornely, OA; de la Villa, S; Dupont, D; Falces-Romero, I; Ferreira-Paim, K; Gangneux, JP; Garcia-Vidal, C; Giacobbe, DR; Hanses, F; Hoyo, I; Koehler, P; Machado, M; Malaj, X; Meis, JF; Rodríguez-Guardado, A; Sal, E; Salmanton-García, J; Schroeder, M; Seidel, D; Sprute, R; Stemler, J; Valerio, M1
Hamada, N; Horiuchi, T; Ishiga, M; Itano, J; Kimura, G; Ooue, Y; Suwaki, T; Tanaka, H; Tanaka, S; Tanimoto, Y; Yuzurio, S1
Abe, K; Abe, Y; Hasegawa, Y; Hishida, T; Kitagawa, Y; Kitago, M; Obara, H; Shinoda, M; Uno, S; Yagi, H1
Bacle, A; Boglione-Kerrien, C; Gangneux, JP; Le Daré, B; Reizine, F1
Agarwal, R; Aggarwal, AN; Chakrabarti, A; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS1
Ashizawa, N; Hirayama, T; Imamura, Y; Ito, Y; Izumikawa, K; Koga, S; Miyazaki, T; Mukae, H; Nakano, Y; Saijo, T; Takazono, T; Tashiro, M; Yamamoto, K; Yanagihara, K1
Bakir Ekinci, P; Demirkan, K; Er, AG; Inkaya, AC; Kara, E; Uzun, O1
Chong, W; Saha, BK1
Ladak, K; Rubin, L1
Alffenaar, JWC; Brüggemann, RJM; Dekkers, BGJ; Groeneveld, GH; Henriet, SSV; Lashof, AMLO; Muilwijk, EW; Russel, FGM; van de Veerdonk, F; van der Hoeven, J; Verweij, PE; Witjes, B1
Harris, C; Morales, MK; Shoham, S1
Lu, G; Shen, Y; Yang, Q; Yao, Y; Yu, Y; Zhou, H; Zhou, J1
Hashizume, H; Kageyama, R; Kaneko, Y1
Agard, E; Chehab, HE; Dot, C; Dot, JM; Douma, I; Mounier, A; Vie, AL1
Chi, YM; Di, QG; Du, JF; Jiang, MM; Li, M; Lv, J; Mai, ZT; Shi, J; Song, Z; Sun, BH1
Bongomin, F; Denning, DW; Harris, C; Hayes, G; Kosmidis, C1
Ganaie, MB; Mahmood, A; Piracha, S; Qayyum, N1
Agarwal, R; Bishnoi, A; Handa, S; Sehgal, IS1
Kasai, H; Nakajima, T; Tanabe, N; Tatsumi, K; Uehara, Y; Yoshino, I1
Gong, BF; Gong, XY; Gu, RX; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Qiu, SW; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL1
Ameur, SB; Bahloul, M; Bouaziz, M; Chabchoub, I; Hachicha, M; Kamoun, T; Kolsi, R; Maaloul, I1
Chen, TW; Chiu, YC; Fan, HL; Ho, MH; Hsieh, CB1
Gohar Ali, M; Qamar, FN; Zubairi, ABS1
Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R1
Aoshima, M; Hashizume, H; Ito, T; Masuda, Y; Miyazawa, H; Shimauchi, T; Tokura, Y1
Ando, T; Fujiuchi, S; Hayashi, Y; Ichihara, K; Imamura, Y; Izumikawa, K; Kakeya, H; Kishi, K; Kohno, S; Miyazaki, T; Miyazaki, Y; Mukae, H; Ogawa, K; Saijo, T; Takazono, T; Tashiro, M; Tokimatsu, I; Yamamoto, K; Yanagihara, K1
Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sehra, G; Strong, P1
Cao, B; Liu, ZB; Wan, J; Xie, WM; Zhai, ZG1
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H1
Campoli, C; Capone, A; Chiappetta, D; Chinello, P; Di Bella, S; Petrosillo, N1
El-Sherief, A; Gordon, S; Olbrych, T; Tedja, R1
Fox, DA; Gladue, HS1
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M1
Bucknor, MD; Gross, AJ; Link, TM1
Fujii, T; Hirota, K; Inagaki, N; Yasoda, A1
Feng, XW; Qu, WX; Zhao, L1
Chan, T; Ding, WY; McWilliams, R; Yadavilli, RK1
Barutcu, E; Celik, AD; Pamuk, GE; Pamuk, ON1
Brown, EV; Davoodi, P; Perry, JR; Wright, SA1
Audagnotto, S; Baietto, L; Bonora, S; Calcagno, A; D'Avolio, A; De Rosa, FG; Di Perri, G; Pagani, N; Simiele, M1
Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y1
Braggio, P; Cascio, GL; Cazzadori, A; Concia, E; Conti, M; Cucchetto, G1
Cheng, Y; Mu, X; Nie, L; Wang, G; Yu, J1
Akinlolu, Y; Chaparro, C; Howard, SJ; Husain, S; Keshavjee, S; Luong, ML; Mazzulli, T; Richardson, S; Rotstein, C; Shalhoub, S; Singer, LG1
Kuribayashi, F; Ochi, N; Takigawa, N; Yamagishi, T; Yamane, H1
Dabó, H; Gomes, I; Marinho, A1
Cunningham, L; Gallagher, C; Keating, C; Lally, A; McKone, E; Moran, M1
Betancourt, BY; Boma, N; Garofoli, AC; Sandhu, JS; Sy, AM1
Mahfoudhi, M; Turki, S1
Lopez, JL; Tayek, JA1
Yaguchi, T1
Burgess, M; Lataifeh, AR; Meena, N1
Shao, J; Xu, J; Zheng, X1
Li, L; Ning, H; Shao, HX; Wang, CZ; Wang, YM; Wu, Q; Xing, ZH1
Izumikawa, K; Tashiro, M1
Bhalla, AS; Guleria, R; Hadda, V; Khandelwal, R; Khilnani, GC; Madan, K; Mohan, A; Poulose, R; Tiwari, P1
Hasegawa, A; Kamata, H; Kano, R; Kimura, S; Lim, SY; Ooya, K; Yanai, T1
Ishida, T; Izumi, S; Kamei, K; Kuwata, H; Sakurai, A; Yanai, H1
Iseman, MD; Peloquin, CA; Schwiesow, JN1
Kanazawa, K; Niki, Y; Takemoto, K; Ueda, Y; Yamamoto, Y; Yoshida, K1
Baba, T; Endo, T; Enomoto, T; Hagiwara, E; Kato, T; Komatsu, S; Matsushima, A; Nishihira, R; Ogura, T; Sekine, A; Shiihara, J; Shinohara, T; Sogo, Y; Tagawa, A; Takahashi, H; Tsuchiya, N1
Maertens, J; Meersseman, W; Van Bleyenbergh, P1
Ayats, J; Fernández, N; Gasch, O; Santin, M1
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ1
Han, FC; Jureen, R; Tew, CW; Tey, BH1
Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY1
Alffenaar, JW; Daenen, SM; Kosterink, JG; Uges, DR; van der Elst, KC1
Altman, R; Belperio, JA; Eshaghian, P; Gregson, A; Kubak, B; Lynch, JP; Ross, DJ; Saggar, R; Wang, T; Wang, TF; Weigt, SS1
Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H1
Duval, A; Hickman, G; Petit, A; Picard, C1
Wingard, J1
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J1
Chudgar, SM; Norton, BL; Person, AK; Stout, JE; Tong, BC1
Segal, BH; Sherif, R1
Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T1
Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y1
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS1
Meersseman, W1
Ahmad, S; Burhamah, MHA; Khan, ZU; Mokaddas, E1
Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N1
Huang, Y; Li, HY; Liu, L; Wang, GY; Xia, ZF; Zhang, JR; Zhu, SH1
Bierings, MB; Melchers, WJ; Thors, VS; Verweij, PE; Wolfs, TF1
Ayub, A; Kenney, CV; McKiernan, FE1
Bedouch, P; Belaiche, S; Pison, C; Quetant, S; Roustit, M; Saint-Raymond, C1
Kuithan, F; Scheer, F; Wiggermann, P1
Pena, TA; Samavati, L; Soubani, AO1
Hoshika, Y; Kato, M; Katsura, Y; Kikuchi, K; Misawa, S; Nagaoka, T; Ohashi, R; Seyama, K; Sugawara, T; Takahashi, K; Takekawa, H; Togo, S; Tsuchiya, K; Yoshimi, K1
Brizio, A; Cantoni, S; Lombardi, G; Morra, E; Nosari, A; Riva, M1
Malfertheiner, MV; Schreiber, J; Waldburg, N1
Bignell, EM; Cairns, T; Doyle, S; Kavanagh, K; Larsen, TO; Miggin, SM; O'Hanlon, KA; O'Keeffe, G; Schrettl, M; Stack, D1
Björkholm, M; Celsing, F; Grane, P; Kalin, M1
Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E1
Bahlaoui, A; Bakhatar, A; Chakib, A; El Fane, M; El Filali, KM; Ouladlahsen, A; Sodqi, M1
Alcazar-Fuoli, L; Bignell, E; Blatzer, M; Cairns, T; Grimalt, JO; Gründlinger, M; Haas, H; Lopez, JF; Puempel, T; Yasmin, S1
Kikuti, K1
Andersen, CU; Bendstrup, E; Henning, O; Hilberg, O; Lundby, T; Mortensen, J1
Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M1
Debaveye, Y; Grootaert, V; Meyfroidt, G; Spriet, I; Willems, L1
Chandrasekar, PH; Cutright, JL; Krishnan Natesan, S; Wu, W1
Fujiuchi, S; Kato, T; Kawabata, M; Kuba, M; Kurashima, A; Ogawa, K; Saito, T; Sakatani, M; Sasaki, Y; Suzuki, K; Tada, A; Tao, Y1
Campo, S; De Santis, R; Lo Giudice, P; Salvatori, G1
Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC1
Del Rosario, RC; Halloush, RA; Khasawneh, FA1
Clauss, H; Samuel, R1

Reviews

17 review(s) available for voriconazole and Pulmonary Aspergillosis

ArticleYear
Management of pulmonary aspergillosis in children: a systematic review.
    Italian journal of pediatrics, 2023, Mar-28, Volume: 49, Issue:1

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Mannans; Pulmonary Aspergillosis; Sensitivity and Specificity; Voriconazole

2023
Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review.
    Journal de mycologie medicale, 2023, Volume: 33, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Pulmonary Aspergillosis; Voriconazole

2023
[Anti-infective treatment of fungal infections by Candida and Aspergillus].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2023, Volume: 118, Issue:6

    Topics: Antifungal Agents; Aspergillus; Candida; Candidemia; Candidiasis, Invasive; Humans; Invasive Fungal Infections; Pulmonary Aspergillosis; Voriconazole

2023
Pulmonary Mycobacterium parascrofulaceum Infection in a Patient with Chronic Progressive Pulmonary Aspergillosis: A Case Report and Literature Review.
    Internal medicine (Tokyo, Japan), 2020, Jun-01, Volume: 59, Issue:11

    Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Chronic Disease; Coinfection; Female; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole

2020
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
    Expert review of respiratory medicine, 2020, Volume: 14, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole

2020
Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Administration, Oral; Antifungal Agents; Cardiotoxicity; Humans; Itraconazole; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole

2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
    The Lancet. Infectious diseases, 2021, Volume: 21, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Azoles; Coinfection; COVID-19; Humans; Nitriles; Pulmonary Aspergillosis; Pyridines; SARS-CoV-2; Triazoles; Voriconazole

2021
Invasive pulmonary aspergillosis after liver transplantation: lessons from successfully treated cases and review of the literature.
    Surgery today, 2021, Volume: 51, Issue:8

    Topics: Clinical Decision-Making; Female; Humans; Incidence; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Retrospective Studies; Risk Factors; Tissue Donors; Treatment Outcome; Voriconazole

2021
Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
    Mycoses, 2021, Volume: 64, Issue:9

    Topics: Antifungal Agents; Echinocandins; Humans; Itraconazole; Network Meta-Analysis; Observational Studies as Topic; Pulmonary Aspergillosis; Randomized Controlled Trials as Topic; Voriconazole

2021
Graded isavuconazole introduction in a patient with voriconazole allergy.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:6

    Topics: Amphotericin B; Angioedema; Antifungal Agents; Aspergillus; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Liver Cirrhosis; Liver Transplantation; Lung; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2017
Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Aged; Antifungal Agents; Chemoprevention; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature.
    Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:1

    Topics: Adult; Antifungal Agents; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Dyslipidemias; Gastroesophageal Reflux; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Jaundice, Obstructive; Lansoprazole; Liver; Male; Polypharmacy; Proton Pump Inhibitors; Pulmonary Aspergillosis; Simvastatin; Voriconazole

2016
The Current Status of Drug-resistant Aspergillus.
    Medical mycology journal, 2016, Volume: 57, Issue:3

    Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Japan; Mutation; Pulmonary Aspergillosis; Voriconazole

2016
Possible relationship between organizing pneumonia and chronic pulmonary aspergillosis: A case report and literature review.
    Respiratory investigation, 2017, Volume: 55, Issue:1

    Topics: Aged; Antifungal Agents; Chronic Disease; Cryptogenic Organizing Pneumonia; Humans; Male; Pneumonectomy; Prednisolone; Pulmonary Aspergillosis; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2017
New therapies for fungal pneumonia.
    Current opinion in infectious diseases, 2009, Volume: 22, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole

2009
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
    Current opinion in pulmonary medicine, 2010, Volume: 16, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole

2010
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
    Lung, 2011, Volume: 189, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole

2011

Trials

5 trial(s) available for voriconazole and Pulmonary Aspergillosis

ArticleYear
The effects of antifungal therapy on the recurrence of aspergillus infection after pulmonary aspergilloma resection: a study protocol for a single-center, prospective, non-blind, randomized, 24-month, parallel group study.
    BMC pulmonary medicine, 2021, Oct-29, Volume: 21, Issue:1

    Topics: Antifungal Agents; Aspergillus; China; Humans; Program Development; Prospective Studies; Pulmonary Aspergillosis; Recurrence; Voriconazole

2021
Efficacy of Intrabronchial Voriconazole Instillation for Inoperable Pulmonary Aspergilloma: A Pilot Randomized Controlled Trial.
    Respiration; international review of thoracic diseases, 2022, Volume: 101, Issue:9

    Topics: Adult; Female; Hemoptysis; Humans; Lung; Pilot Projects; Pulmonary Aspergillosis; Voriconazole

2022
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole

2023
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
    The Journal of infection, 2010, Volume: 61, Issue:5

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2010
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2012

Other Studies

114 other study(ies) available for voriconazole and Pulmonary Aspergillosis

ArticleYear
[Analysis of four cases with congenital pulmonary airway malformation complicated by chronic pulmonary aspergillosis].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2021, Oct-02, Volume: 59, Issue:10

    Topics: Adolescent; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Child; Female; Humans; Male; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2021
Chronic cavitary pulmonary aspergillosis in an infant.
    The Lancet. Infectious diseases, 2021, Volume: 21, Issue:12

    Topics: Antifungal Agents; Female; Humans; Infant; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Voriconazole

2021
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
    Chest, 2022, Volume: 161, Issue:1

    Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole

2022
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
    Infection, 2023, Volume: 51, Issue:1

    Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Female; Fluconazole; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole

2023
Manifestations, Prevalence, Management and Outcome of Invasive
    Current drug safety, 2024, Volume: 19, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Cross-Sectional Studies; Humans; Liver Transplantation; Mycoses; Prevalence; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2024
Positive correlation between voriconazole trough concentrations and C-reactive protein levels in patients with chronic pulmonary aspergillosis: A retrospective cohort study.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:7

    Topics: Antifungal Agents; C-Reactive Protein; Creatinine; Humans; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2023
Repeated spontaneous remission of acute myeloid leukemia in response to various infections: a case report.
    BMC infectious diseases, 2023, Apr-06, Volume: 23, Issue:1

    Topics: Aged; Aged, 80 and over; Escherichia coli; Escherichia coli Infections; Female; Humans; Leukemia, Myeloid, Acute; Pulmonary Aspergillosis; Remission, Spontaneous; Voriconazole

2023
Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:7

    Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole

2023
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study.
    Medical mycology, 2023, Jun-05, Volume: 61, Issue:6

    Topics: Animals; Antifungal Agents; COVID-19; Pulmonary Aspergillosis; Retrospective Studies; Triazoles; Voriconazole

2023
Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.
    Antimicrobial agents and chemotherapy, 2023, 10-18, Volume: 67, Issue:10

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Voriconazole

2023
Feasibility and safety of uniportal thoracoscopy for chronic pulmonary aspergillosis.
    Scientific reports, 2023, 09-30, Volume: 13, Issue:1

    Topics: Antifungal Agents; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Pulmonary Aspergillosis; Retrospective Studies; Thoracic Surgery, Video-Assisted; Voriconazole

2023
    BMJ case reports, 2020, Mar-17, Volume: 13, Issue:3

    Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Carcinoma, Squamous Cell; Fungemia; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Thyroid Neoplasms; Vancomycin; Voriconazole

2020
COVID-19 associated pulmonary aspergillosis.
    Mycoses, 2020, Volume: 63, Issue:6

    Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Galactose; Germany; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Lung Diseases; Male; Mannans; Metapneumovirus; Middle Aged; Nitriles; Pandemics; Paramyxoviridae Infections; Pneumonia, Viral; Pulmonary Aspergillosis; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Triazoles; Voriconazole

2020
Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
    Medical mycology, 2020, Oct-01, Volume: 58, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; United Kingdom; Voriconazole; Weight Loss

2020
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    JAMA dermatology, 2020, 07-01, Volume: 156, Issue:7

    Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole

2020
The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
    Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Carcinoma, Squamous Cell; Chronic Disease; England; Female; Humans; Incidence; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Risk Assessment; Risk Factors; Skin Neoplasms; Time Factors; Treatment Outcome; Voriconazole; Young Adult

2020
Chronic granulomatous 'Aspergillus lung mass'.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Sep-07, Volume: 90, Issue:3

    Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillus; Chest Pain; Granulomatous Disease, Chronic; Hemoptysis; Humans; Image-Guided Biopsy; Incidental Findings; Lung Diseases, Fungal; Male; Pneumonectomy; Postoperative Care; Pulmonary Aspergillosis; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2020
Cavernoscopic Views of a Pleural Aspergillosis.
    American journal of respiratory and critical care medicine, 2021, 01-01, Volume: 203, Issue:1

    Topics: Antifungal Agents; Aspergillus fumigatus; Humans; Male; Middle Aged; Pleural Diseases; Pulmonary Aspergillosis; Thoracoscopy; Treatment Outcome; Voriconazole

2021
A Neonate With Fungal Lung Nodules Mimicking Pulmonary Malignancy.
    The Pediatric infectious disease journal, 2020, Volume: 39, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Humans; Infant, Newborn; Male; Pulmonary Aspergillosis; Voriconazole

2020
Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention.
    Journal of nanobiotechnology, 2021, Jan-11, Volume: 19, Issue:1

    Topics: A549 Cells; Administration, Inhalation; Animals; Antifungal Agents; Cell Survival; Chitosan; Clathrin; Drug Carriers; Drug Delivery Systems; Humans; Lipids; Lung; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polymers; Pulmonary Aspergillosis; Voriconazole

2021
Lung aspergilloma with pituitary invasive aspergillosis presenting as headache and hyponatraemia.
    BMJ case reports, 2021, Jan-27, Volume: 14, Issue:1

    Topics: Aged; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Endoscopy; Headache; Hemoptysis; Humans; Hypertension; Hyponatremia; Hypopituitarism; Inappropriate ADH Syndrome; Magnetic Resonance Imaging; Male; Neuroaspergillosis; Pituitary Diseases; Pulmonary Aspergillosis; Renal Insufficiency, Chronic; Sphenoid Sinusitis; Thoracic Surgery, Video-Assisted; Voriconazole

2021
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
    Emerging infectious diseases, 2021, Volume: 27, Issue:4

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; COVID-19; Female; Humans; Immunologic Factors; Incidence; Intensive Care Units; International Cooperation; Male; Outcome and Process Assessment, Health Care; Pulmonary Aspergillosis; Registries; Respiration, Artificial; Risk Factors; SARS-CoV-2; Voriconazole

2021
Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis.
    Internal medicine (Tokyo, Japan), 2021, Aug-01, Volume: 60, Issue:15

    Topics: Amphotericin B; Antifungal Agents; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Voriconazole

2021
Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.
    Critical care (London, England), 2021, 04-20, Volume: 25, Issue:1

    Topics: Antifungal Agents; COVID-19; Drug Administration Schedule; Evidence-Based Medicine; Female; Humans; Male; Pulmonary Aspergillosis; Voriconazole

2021
Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report.
    BMC infectious diseases, 2021, Jun-14, Volume: 21, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Azoles; Chronic Disease; Drug Resistance, Fungal; Fungal Proteins; Humans; Male; Microbial Sensitivity Tests; Mutation; Phenotype; Pulmonary Aspergillosis; Virulence; Voriconazole

2021
Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:3

    Topics: Antifungal Agents; COVID-19; Humans; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole

2022
A 61-Year-Old Man With Influenza Pneumonia and New Onset Hemoptysis.
    Chest, 2021, Volume: 160, Issue:2

    Topics: Antifungal Agents; Diagnosis, Differential; Diagnostic Imaging; Fatal Outcome; Hemoptysis; Humans; Influenza, Human; Male; Middle Aged; Pneumonia, Viral; Pulmonary Aspergillosis; Voriconazole

2021
Voriconazole-Induced Periostitis Deformans: A Mimicker of Hypertrophic Pulmonary Osteoarthropathy.
    Clinical medicine & research, 2017, Volume: 15, Issue:1-2

    Topics: Adult; Cystic Fibrosis; Humans; Lung Transplantation; Male; Osteoarthropathy, Primary Hypertrophic; Periostitis; Pulmonary Aspergillosis; Voriconazole

2017
Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus; Child; Child, Preschool; Drug Interactions; Female; Floxacillin; Granulomatous Disease, Chronic; Humans; Invasive Fungal Infections; Male; Middle Aged; Pulmonary Aspergillosis; Voriconazole; Young Adult

2017
Serum Aspergillus fumigatus-specific IgG antibody decreases after antifungal treatment in chronic pulmonary aspergillosis patients.
    The clinical respiratory journal, 2018, Volume: 12, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Humans; Immunoglobulin G; Male; Middle Aged; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole; Young Adult

2018
Agranulocytosis associated with voriconazole-induced hypersensitivity syndrome.
    The Journal of dermatology, 2018, Volume: 45, Issue:5

    Topics: Aged; Agranulocytosis; Antifungal Agents; Drug Hypersensitivity Syndrome; Female; Humans; Meropenem; Pulmonary Aspergillosis; Skin; Voriconazole

2018
Macular toxicity and blind spot enlargement during a treatment by voriconazole: A case report.
    European journal of ophthalmology, 2018, Volume: 28, Issue:4

    Topics: Aged; Antifungal Agents; Electroretinography; Evoked Potentials, Visual; Humans; Macula Lutea; Male; Pulmonary Aspergillosis; Retinal Diseases; Tomography, Optical Coherence; Visual Acuity; Voriconazole

2018
Clinical efficacy of sequential therapy with voriconazole on COPD patients in acute phase with pulmonary aspergillosis and effects on cytokines and pulmonary functions.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Cytokines; Female; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Voriconazole

2018
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
    PloS one, 2018, Volume: 13, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Body Weight; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult

2018
Massive haemoptysis secondary to mycotic pulmonary artery aneurysm in subacute invasive aspergillosis.
    BMJ case reports, 2018, Apr-19, Volume: 2018

    Topics: Aneurysm, Infected; Antifungal Agents; Bronchoscopy; Computed Tomography Angiography; Embolization, Therapeutic; Fatal Outcome; Hemoptysis; Humans; Male; Middle Aged; Pneumonia; Pulmonary Aspergillosis; Sepsis; Voriconazole

2018
Painful fingernails in a patient with chronic fibrosing pulmonary aspergillosis.
    European journal of internal medicine, 2019, Volume: 59

    Topics: Chronic Disease; Dermatitis, Phototoxic; Humans; Male; Middle Aged; Onycholysis; Pain; Photosensitivity Disorders; Pulmonary Aspergillosis; Voriconazole

2019
Aspergillus Sternomyelitis Developed from Chronic Pulmonary Aspergillosis as a Late Complication to Lobectomy for Lung Cancer.
    Internal medicine (Tokyo, Japan), 2018, Oct-15, Volume: 57, Issue:20

    Topics: Aged; Anti-Bacterial Agents; Humans; Lung Diseases, Fungal; Lung Neoplasms; Male; Myelitis, Transverse; Pneumonectomy; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole

2018
[Primary Prophylatic Effect of Voriconazole Against Invasive Infection of Pulmonary Aspergillosis during Remission-Induction Chemotherapy for Acute Myeloid Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2018, Volume: 26, Issue:5

    Topics: Antifungal Agents; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Mycoses; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2018
Fulminant mulch pneumonitis in a previously healthy child.
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2018, Volume: 25, Issue:8

    Topics: Antifungal Agents; Child; Diagnosis, Differential; Glucocorticoids; Granulomatous Disease, Chronic; Humans; Male; Pneumonia; Pulmonary Aspergillosis; Voriconazole

2018
Twice-Weekly Tacrolimus Can Overcome Pharmacologic Interaction and Help in the Successful Treatment of Pulmonary Aspergillosis in a Liver Transplant Recipient.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2019, Volume: 17, Issue:6

    Topics: Antifungal Agents; Calcineurin Inhibitors; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Pulmonary Aspergillosis; Tacrolimus; Treatment Outcome; Voriconazole

2019
Large mediastinal mass in a 15-year-old boy.
    BMJ case reports, 2018, Nov-08, Volume: 2018

    Topics: Adolescent; Antifungal Agents; Biopsy; Bronchoscopy; Diagnosis, Differential; Humans; Job Syndrome; Male; Mediastinum; Pulmonary Aspergillosis; Radiography, Interventional; Tomography, X-Ray Computed; Voriconazole

2018
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
    Mycoses, 2019, Volume: 62, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole

2019
Voriconazole-photoinduced polyomavirus-negative Merkel cell carcinoma.
    The Journal of dermatology, 2019, Volume: 46, Issue:8

    Topics: Antifungal Agents; Biopsy; Carcinoma, Merkel Cell; Churg-Strauss Syndrome; Glucocorticoids; Humans; Male; Merkel cell polyomavirus; Middle Aged; Pulmonary Aspergillosis; Skin; Skin Neoplasms; Sunlight; Time Factors; Voriconazole

2019
Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 02-14, Volume: 70, Issue:5

    Topics: Aged; Antifungal Agents; Follow-Up Studies; Humans; Itraconazole; Maintenance; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2020
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
    Scientific reports, 2019, 07-01, Volume: 9, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Benzamides; Cell Line; Drug Synergism; Humans; Pulmonary Alveoli; Pulmonary Aspergillosis; Triazoles; Voriconazole

2019
Pulmonary aspergillosis with in-situ pulmonary artery thrombosis: to anti-coagulate or not?
    Chinese medical journal, 2019, Jul-20, Volume: 132, Issue:14

    Topics: Aged; Anticoagulants; Computed Tomography Angiography; Humans; Male; Pulmonary Artery; Pulmonary Aspergillosis; Pulmonary Circulation; Thrombosis; Voriconazole

2019
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
    BMC infectious diseases, 2013, Feb-26, Volume: 13

    Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2013
Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.
    Mycopathologia, 2013, Volume: 175, Issue:3-4

    Topics: Aged; Antifungal Agents; Humans; Lung; Male; Mycetoma; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2013
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2013, Volume: 19, Issue:8

    Topics: Aged; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Diagnosis, Differential; Disease Progression; Female; Granulomatosis with Polyangiitis; Hip Joint; Humans; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
    Mycopathologia, 2014, Volume: 177, Issue:1-2

    Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole

2014
Voriconazole-induced periostitis in two post-transplant patients.
    Journal of radiology case reports, 2013, Volume: 7, Issue:8

    Topics: Antifungal Agents; Female; Heart Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Periostitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Voriconazole-induced periostitis in a patient with overlap syndromes.
    BMJ case reports, 2014, Mar-05, Volume: 2014

    Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Middle Aged; Periostitis; Pulmonary Aspergillosis; Rheumatic Diseases; Voriconazole

2014
Successful treatment of larynx-tracheobronchial-pulmonary aspergillosis in an immunocompetent host.
    Genetics and molecular research : GMR, 2014, Feb-14, Volume: 13, Issue:4

    Topics: Amphotericin B; Bronchi; Bronchoscopy; Female; Fiber Optic Technology; Humans; Immunocompetence; Larynx; Middle Aged; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Trachea; Voriconazole

2014
Aspergilloma and massive haemoptysis.
    BMJ case reports, 2014, Apr-16, Volume: 2014

    Topics: Adult; Aneurysm, False; Angiography; Antifungal Agents; Embolization, Therapeutic; Female; Hemoptysis; Humans; Ill-Housed Persons; Mycetoma; Pulmonary Artery; Pulmonary Aspergillosis; Pyrimidines; Severity of Illness Index; Substance Abuse, Intravenous; Tomography, X-Ray Computed; Triazoles; Voriconazole

2014
The development of pulmonary aspergillosis and pneumothorax in a patient with neutropenic systemic lupus erythematosus and successful treatment of the first case.
    BMJ case reports, 2014, May-21, Volume: 2014

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Drainage; Female; Humans; Lupus Erythematosus, Systemic; Neutropenia; Opportunistic Infections; Pneumothorax; Prednisolone; Pulmonary Aspergillosis; Staphylococcal Infections; Staphylococcus aureus; Voriconazole; Young Adult

2014
Rare diagnosis in a neonate who presents with fever.
    Clinical pediatrics, 2015, Volume: 54, Issue:1

    Topics: Anti-Infective Agents; Antifungal Agents; Biopsy; Diagnosis, Differential; Fever; Granulomatous Disease, Chronic; Humans; Infant, Newborn; Itraconazole; Lung; Male; Pulmonary Aspergillosis; Radiography, Interventional; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole

2015
Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction.
    Pharmacogenomics, 2014, Volume: 15, Issue:10

    Topics: Adult; Aged; Atazanavir Sulfate; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Genotype; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oligopeptides; Pulmonary Aspergillosis; Pyridines; Ritonavir; Voriconazole

2014
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2014, Volume: 88, Issue:4

    Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2014
Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.
    Infection, 2015, Volume: 43, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Longitudinal Studies; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult

2015
[Mixed types of pulmonary aspergillosis].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2014, Volume: 37, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2014
Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4

    Topics: Antifungal Agents; Aspergillus fumigatus; Chemoprevention; Cytochrome P-450 Enzyme System; Fungal Proteins; Humans; Lung Transplantation; Mutation Rate; Prospective Studies; Pulmonary Aspergillosis; Transplant Recipients; Voriconazole

2015
A 60-year-old asymptomatic woman with pulmonary lesions and cervical lymphadenopathy.
    Chest, 2015, Volume: 147, Issue:2

    Topics: Antifungal Agents; Antigens, Fungal; Asymptomatic Infections; Comorbidity; Female; Granulomatous Disease, Chronic; Humans; Liver Abscess; Lymph Nodes; Lymphatic Diseases; Membrane Glycoproteins; Middle Aged; Mutation, Missense; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Voriconazole

2015
Pulmonary Aspergillus Nodule--Still Challenging?
    Archivos de bronconeumologia, 2015, Volume: 51, Issue:11

    Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Chemical and Drug Induced Liver Injury; Chronic Disease; Diagnosis, Differential; Drug Resistance, Fungal; Drug Substitution; Female; Hemoptysis; Humans; Itraconazole; Lung Neoplasms; Middle Aged; Pulmonary Aspergillosis; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Voriconazole

2015
Recall of provision of sun protection measures to patients with cystic fibrosis being prescribed voriconazole.
    Photodermatology, photoimmunology & photomedicine, 2015, Volume: 31, Issue:6

    Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Middle Aged; Patient Education as Topic; Pulmonary Aspergillosis; Skin Neoplasms; Sunburn; Sunlight; Voriconazole; Young Adult

2015
Pulmonary aspergillosis presenting with recurrent haemoptysis.
    BMJ case reports, 2015, Jul-07, Volume: 2015

    Topics: Antifungal Agents; Aspergillus fumigatus; Cough; Hemoptysis; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Recurrence; Treatment Outcome; Tuberculosis, Pulmonary; Voriconazole

2015
[Excavated persistent pulmonary opacities during a granulomatosis with polyangiitis: think of aspergillosis].
    The Pan African medical journal, 2015, Volume: 20

    Topics: Antibodies, Antineutrophil Cytoplasmic; Antifungal Agents; Aspergillus fumigatus; Biopsy; Granulomatosis with Polyangiitis; Hemoptysis; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Voriconazole

2015
Deep-seated mycosis. Aspergillus lentulus.
    Medical mycology journal, 2015, Volume: 56, Issue:4

    Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Humans; Itraconazole; Microscopy, Electron, Scanning Transmission; Pulmonary Aspergillosis; Sputum; Voriconazole

2015
Chronic pulmonary aspergillosis: help is on the way.
    The Lancet. Respiratory medicine, 2016, Volume: 4, Issue:2

    Topics: Antifungal Agents; Chronic Disease; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Practice Guidelines as Topic; Pulmonary Aspergillosis; Voriconazole

2016
Pleuroscopy With a Bronchoscope.
    Journal of bronchology & interventional pulmonology, 2016, Volume: 23, Issue:2

    Topics: Aged; Antifungal Agents; Bronchoscopes; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Thoracoscopy; Treatment Outcome; Voriconazole

2016
Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis.
    The American journal of the medical sciences, 2016, Volume: 352, Issue:2

    Topics: Aged; Amphotericin B; Antifungal Agents; Bronchoscopy; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Male; Pulmonary Aspergillosis; Tomography Scanners, X-Ray Computed; Voriconazole

2016
Cystic Bronchiectasis Imitating Pulmonary Aspergilloma.
    Chinese medical journal, 2016, 09-05, Volume: 129, Issue:17

    Topics: Aged; Antifungal Agents; Bronchiectasis; Female; Humans; Pulmonary Aspergillosis; Tomography, X-Ray Computed; Voriconazole

2016
Intrabronchial Voriconazole is a Safe and Effective Measure for Hemoptysis Control in Pulmonary Aspergilloma.
    Journal of bronchology & interventional pulmonology, 2017, Volume: 24, Issue:1

    Topics: Adult; Bronchoscopy; Female; Hemoptysis; Humans; Instillation, Drug; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome; Voriconazole

2017
The First Isolation of Aspergillus allahabadii from a Cormorant with Pulmonary Aspergillosis.
    Medical mycology journal, 2016, Volume: 57, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Bird Diseases; Birds; Child; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole

2016
Concomitant use of voriconazole and rifabutin in a patient with multiple infections.
    Pharmacotherapy, 2008, Volume: 28, Issue:8

    Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Aspergillus fumigatus; Drug Interactions; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Pulmonary Aspergillosis; Pyrimidines; Rifabutin; Triazoles; Voriconazole

2008
Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
    Chemotherapy, 2009, Volume: 55, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Lung; Male; Mice; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
[Usefulness of monitoring plasma voriconazole concentration in patients with chronic necrotizing pulmonary aspergillosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:2

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole

2009
Aspergillus vertebral osteomyelitis and epidural abscess.
    Singapore medical journal, 2009, Volume: 50, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Epidural Abscess; Fatal Outcome; Humans; Infusions, Intravenous; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Spinal Cord Compression; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole

2009
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
    Thorax, 2009, Volume: 64, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole

2009
Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage.
    British journal of clinical pharmacology, 2009, Volume: 68, Issue:3

    Topics: Anticonvulsants; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Phenytoin; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:12

    Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; Lung Transplantation; Male; Middle Aged; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
    Medical mycology, 2010, Volume: 48, Issue:1

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2010
[Porphyria cutanea tarda revealed by voriconazole].
    Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:1

    Topics: Aged; Alcoholism; Antifungal Agents; Cheilitis; Feces; Humans; Liver; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Uroporphyrinogen Decarboxylase; Voriconazole

2010
Antifungal management.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
    Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis.
    Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 7

    Topics: Aged; Antifungal Agents; Aspergillus niger; Female; Humans; Lung; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:12

    Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
    Pediatric pulmonology, 2010, Volume: 45, Issue:7

    Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole

2010
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
    Pediatric hematology and oncology, 2010, Volume: 27, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2010
Case report 2: Fungal infections in chronic obstructive pulmonary disease.
    Mycoses, 2010, Volume: 53 Suppl 2

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Belgium; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography, Thoracic; Steroids; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
    Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 12

    Topics: Antifungal Agents; beta-Glucans; Child; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Pulmonary aspergillosis in a non-neutropenic critical patient.
    The Journal of trauma, 2010, Volume: 69, Issue:4

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Burns, Inhalation; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Hydrogen Sulfide; Intensive Care Units; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Chemoprevention; Child; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Opportunistic Infections; Periostitis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography; Radionuclide Imaging; Triazoles; Voriconazole

2011
Management of voriconazole hepatotoxicity in a lung transplant patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:3

    Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Transplantation; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
[Fatal outcome of invasive tracheal aspergillosis].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2011, Volume: 183, Issue:5

    Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult

2011
Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS).
    Medical mycology journal, 2011, Volume: 52, Issue:1

    Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mycetoma; Paraproteinemias; Pulmonary Aspergillosis; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2011
Oral voriconazole for neutropenia: a leukemia patient with probable pulmonary aspergillosis and scedosporidiosis.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1

    Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Leukemia; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2011
[Intralobar pulmonary sequestration with aspergillosis in an asymptomatic 39-year-old man].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:22

    Topics: Adult; Bronchopulmonary Sequestration; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Radiography; Thoracotomy; Treatment Outcome; Triazoles; Voriconazole

2011
Targeted disruption of nonribosomal peptide synthetase pes3 augments the virulence of Aspergillus fumigatus.
    Infection and immunity, 2011, Volume: 79, Issue:10

    Topics: Animals; Animals, Outbred Strains; Antifungal Agents; Aspergillus fumigatus; Cell Line; Fungal Proteins; Gene Deletion; Macrophages; Mice; Moths; Peptide Synthases; Phenotype; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Virulence; Voriconazole

2011
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
    Infection, 2012, Volume: 40, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Voriconazole-induced QT interval prolongation and torsades de pointes.
    Pediatrics international : official journal of the Japan Pediatric Society, 2011, Volume: 53, Issue:5

    Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole

2011
[Pulmonary aspergillosis and HIV infection: about two cases].
    Revue de pneumologie clinique, 2012, Volume: 68, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Radiography; Risk Factors; Triazoles; Voriconazole

2012
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Feb-21, Volume: 109, Issue:8

    Topics: Amphotericin B; Animals; Aspergillus fumigatus; Biomass; Biosynthetic Pathways; Enoyl-CoA Hydratase; Ergosterol; Ferric Compounds; Gene Deletion; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Gene Silencing; Genes, Fungal; Hydroxamic Acids; Hydroxymethylglutaryl CoA Reductases; Iron Deficiencies; Ligases; Lovastatin; Mevalonic Acid; Mice; Microbial Sensitivity Tests; Oxidative Stress; Pulmonary Aspergillosis; Pyrimidines; Siderophores; Triazoles; Up-Regulation; Virulence; Voriconazole

2012
[Photo quiz: Deep-seated mycosis].
    Medical mycology journal, 2012, Volume: 53, Issue:2

    Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Polymerase Chain Reaction; Pulmonary Aspergillosis; Pyrimidines; RNA, Fungal; Scedosporium; Sputum; Triazoles; Voriconazole

2012
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis.
    The European respiratory journal, 2012, Volume: 40, Issue:1

    Topics: Administration, Inhalation; Aged; Antifungal Agents; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2012
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
    European journal of clinical pharmacology, 2013, Volume: 69, Issue:3

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2013
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2012, Volume: 74, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Mice; Mice, Inbred ICR; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
    Infection, 2012, Volume: 40, Issue:6

    Topics: Aged; Antifungal Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12

    Topics: Animals; Antifungal Agents; Body Burden; C-Reactive Protein; Colony Count, Microbial; Cortisone; Drug Combinations; Galactose; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung; Mannans; Organ Size; Pulmonary Aspergillosis; Pyrimidines; Rats; Respiratory Function Tests; Serum Amyloid P-Component; Survival; Triazoles; Voriconazole

2012
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
    Mycoses, 2013, Volume: 56, Issue:4

    Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
A 56-year-old man with undifferentiated fever in the ICU and endobronchial plaques.
    Chest, 2013, Feb-01, Volume: 143, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Colectomy; Fever; Humans; Intensive Care Units; Intestinal Diseases; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Simultaneous mold infections in an orthotopic heart transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:5

    Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole

2008